Scienmag

DECEMBER 15, 2020

Data analysis offers comparison of the 2 viruses Almost a year ago, COVID-19 began its global rampage, going on to infect about 69.5 million people and kill about 1.6 million as of early this month. From the beginning, most scientists have said that COVID-19 is deadlier than the seasonal flu, while fringe theories have circulated […].

Scientist 75

Scientist Allergies Cardiology Medicine 75

Scienmag

JULY 20, 2021

A scoping review of English and Chinese-language studies found individuals with chronic physical health conditions had higher levels of mental health problems during the COVID-19 pandemic; targeted interventions were lacking A new scoping review found that those with chronic health concerns, such as diabetes, heart disease, cancer, and autoimmune conditions, (..)

Allergies 75

Allergies Cardiology Medicine 75

Scienmag

OCTOBER 21, 2020

Researchers have found that a class of commonly-used heart drugs may also improve patients’ responses to anti-cancer immunotherapies called PD(L)1 inhibitors, according to preliminary findings to be presented at the 32th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics, which is taking place online.

Drugs 73

Drugs Research Clinical Trials Clinical Trials 73

Scienmag

OCTOBER 20, 2020

Researchers at the University of Toronto have found first evidence that neutrophil immune cell activity is the missing link connecting periodontal disease with heart disease, cancer, and other inflammatory conditions Credit: Noah Fine (TORONTO, ON) Oct.

Research 71

Research Allergies Cardiology Medicine 71

XTalks

AUGUST 2, 2023

With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions. In this in-depth article, we embark on a captivating journey to uncover the top 30 pharma and biotech companies that have been instrumental in shaping the future of medicine.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Scienmag

OCTOBER 15, 2020

New call to action highlights dual threat of influenza and COVID-19 for US adults with chronic health conditions Washington, DC (October 15, 2020) — The National Foundation for Infectious Diseases (NFID) issued a new Call to Action report detailing the risks of co-infection with influenza (flu) and COVID-19 in adults with chronic health conditions, (..)

Allergies 47

Allergies Cardiology Vaccination Vaccine 47

Scienmag

DECEMBER 1, 2020

IVIg portfolio also featured in study design poster on primary infection prophylaxis in patients with chronic lymphocytic leukemia PARAMUS, N.J.

Clinical Research 46

Clinical Research Research Clinical Trials Clinical Trials 46

Scienmag

JULY 20, 2021

New research published in the European Journal of Clinical Investigation identifies cardiovascular test results that might help to identify patients hospitalized with COVID-19 who face an especially high risk of dying.

Research 46

Research Allergies Cardiology Medicine 46

Scienmag

MARCH 18, 2021

UCLA study suggests new way in which COVID-19 crisis has exacerbated racial health disparities During the first six months of the pandemic, as people attempted to stay away from hospitals caring for those sick with COVID-19, potentially avoidable hospitalizations for non-COVID-19-related conditions fell far more among white patients than Black patients, (..)

Allergies 41

Allergies Cardiology Medicine 41

Scienmag

OCTOBER 23, 2020

CNIC scientists have discovered previously unsuspected actions of the immune system that help to maintain organ health Credit: CNIC Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have discovered that neutrophils, the most abundant cells of the innate immune system, have many more functions in the body than previously thought. (..)

Scientist 41

Scientist Allergies Cardiology Medicine 41

Scienmag

DECEMBER 2, 2020

Research evaluates use of fibryga®, Octaplas™, and Octaplex® as investigational therapies PARAMUS, N.J.

Research 40

Research Clinical Research Clinical Trials Clinical Trials 40

Scienmag

NOVEMBER 17, 2020

Rates of both periodontal disease and cardiovascular disease are elevated in individuals with rheumatoid arthritis. New research published in Arthritis & Rheumatology suggests that immune responses to certain bacteria that cause periodontal disease may play a role in patients’ higher cardiovascular disease risk.

Immune Response 40

Immune Response Bacteria Antibody Research 40

Scienmag

SEPTEMBER 2, 2020

Why so many COVID-19 patients get blood clots (thrombosis) remains uncertain. But scientists at Uppsala University and the University Hospital have now identified a mechanism they believe to be implicated. A particular protein triggers a part of our immune system that can boost the blood’s tendency to coagulate and form clots.

Protein 40

Protein Scientist Allergies Cardiology 40

The Pharma Data

NOVEMBER 4, 2020

Progressed European regulatory review and commercial preparations : Continued to support regulatory review of VASCEPA by the European Medicines Agency (EMA) with the expectation of an early 2021 approval of VASCEPA for commercial sale in Europe. Patients with such allergies should discontinue VASCEPA if any reactions occur.

Sales 40

Sales Production Marketing Cardiology 40